Patient | Age at diagnosis | Gender | Organ involvement | Diabetes | serum IgG4 (ULN=1.4 mg/mL) | IgG4/IgG RNA ratio (ULN=5%) | Response to prednisolone | IgG4 reactivity on western blot | IgG1 Reactivity on western blot |
IRD1 | 52 | M | IAC, AIP, GLA | + | 6,17 | 24,92 | + | + | + |
IRD2 | 53 | M | IAC, AIP, kidney | + | 4,89 | 15,89 | ND | + | + |
IRD3 | 74 | F | IAC, AIP | + | 8,82 | 51,51 | + | + | + |
IRD4 | 69 | M | IAC, kidney, LLA | + | 8,10 | 24,63 | + | + | + |
IRD5 | 49 | M | IAC, AIP, orbits, SMG | + | 14,60 | 30,02 | + | + | + |
IRD6 | 66 | M | IAC, AIP | + | 2,98 | 9,36 | + | + | + |
IRD7 | 64 | M | IAC, LLA | - | 1,74 | 6,89 | + | + | + |
IRD8 | 80 | M | IAC, AIP, larynx | - | 1,40 | 26,04 | + | + | - |
IRD9 | 49 | M | IAC, AIP, LLA | - | 3,75 | 9,63 | ND | + | - |
AIP , autoimmune pancreatitis; GLA, generalised lymphadenopathy; IAC, immunoglobulin G4-associated cholangitis; IRD, immunoglobulin G4-RD; LLN, localised lymphadenopathy; ND, not done; SMG, submandibular glands; ULN, upper limit of normal.